While medicine now has the scientific tools to eliminate cervical cancer, achieving this ambitious goal will require a concerted public health effort including education, planning, and resources to address healthcare inequities through vaccination, screening, and early treatment of the Human Papilloma Virus (HPV)-related infections worldwide. The Fifth Annual “Us vs. HPV” Prevention Week happening January 23-27 aims to support and catalyze this public health effort.
Organized by American Medical Women’s Association (AMWA), Global Initiative Against HPV Cervical Cancer (GIAHC), and Indiana University National Center of Excellence (NCoE) in Women’s Health, this year’s Us vs. HPV program offers daily webinars with renowned medical experts, national and global advocates, patient perspectives, and news and social media outreach. It will spotlight advances in diagnosis, treatment, and prevention of HPV-related cancers. Beyond cervical cancer, HPV is responsible for an estimated 90% of anal cancers, 70% of vaginal and vulvar cancers, and more than 60% of penile cancers. About 80% of people under the age of 50 will have some form of HPV and never know it.
“Given today’s medical advances, it’s heartbreaking that an estimated 300,000 women still die from cervical cancer annually,” said AMWA President, Theresa Rohr-Kirchgraber, MD, FACP, FAMWA, Professor of Medicine at AU/UGA Medical Partnership. “We want to shine a light on disparities that are impacting mortality — in low-to-middle income countries, where the vast majority of cervical cancer cases occur, and in wealthier countries, where inequities persist for many.”
Shobha S. Krishnan, MD, FAAFP, AMWA Board member and Founder and President of GIAHC believes that Us vs. HPV Prevention Week comes at a perfect time. “2023 will be a year to celebrate as we rebound from the pandemic and apply innovations in the field of HPV cancers to achieve health care equity,” she said. “With the introduction of the generic HPV vaccine (India, China), one dose vaccination (WHO), and more accurate and simpler ways to treat early cervical cancer, we will save millions of lives worldwide!”
Learn More & Register for Us vs. HPV Webinars
Webinars Agenda, Us vs. HPV Prevention Week, Jan 23-27, 12-1 pm ET Daily:
Opening from Congresswoman Kim Schrier, MD
- Jan 23 – HPV Prevention Matters
- Jan 24 – Diversifying HPV Efforts for Health Equity
- Jan 25 – Innovations, Empowerment & Solutions in Global Cervical Cancer Prevention
- Jan 26 – Update on HPV-related Head and Neck Cancers; Patient Perspective
- Jan 27 – Raising Awareness to End HPV-Related Cancers
- Global & U.S. advocacy groups
- 2023 HPV and Cervical Cancer Champion Award
Us vs. HPV Prevention Week is free and open to all. Register to view webinars live or to access recordings when available.
AMWA, GIAHC and NCoE thank our many sponsors and supporters.
Sponsors, who have helped to make Us vs. HPV possible include: AHCC Research Association, American Head and Neck Society (AHNS), American Sexual Health Association, American Society for Colposcopy and Cervical Pathology (ASCCP), Australian Centre for the Prevention of Cancer, Cervical Cancer Foundation, Colorectal Wellness Center, HealthyWomen, Medical Women’s International Association, Moffitt Cancer Center, National Association of Nurse Practitioners in Women’s Health (NPWH), National Cervical Cancer Coalition, Planned Parenthood, St. Jude’s Hospital HPV Prevention Program, Prevent Cancer Foundation, Temple University Head & Neck, University of Miami Sylvester Comprehensive Cancer Center, Vaccinate Indiana, the Wellington Group, .
Supporters participating in various ways, including helping to disseminate news of Us vs. HPV include: American Cancer Society, Basic Health International, Cancer Research UK, Clinton Health Access Initiative, Conquering Cancer Campaign, The Center for Global Women’s Health Technologies at Duke University, Grounds for Health, HPV Cancers Alliance, Indiana Commission for Women
American Medical Women’s Association (AMWA) is a multispecialty organization of women physicians committed to advancing women in medicine, advocating for equity, and ensuring excellence in health care.
Global Initiative Against HPV and Cervical Cancer (GIAHC) is a U.S.-based public health-focused advocacy group working to eradicate HPV-related cancers.
Indiana University National Center of Excellence (NCoE) in Women’s Health is part of the Indiana University School of Medicine, the largest medical school in the country.